Company intelligence / Profile preview

TauTona Group

Redwood City, California, United Statestautonagroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

TauTona Group is a vertically-integrated operational fund that creates, invests in, and develops new solutions in medtech, biotech, and regenerative medicine. Founded by Stanford School of Medicine professors with expertise in bioengineering and tissue regeneration, the group focuses on addressing unmet clinical needs by bringing innovations from concept to commercialization. Its unique model allows for rapid evaluation and development of disruptive healthcare solutions at reduced cost[1][2][3].

Modalities: DeviceBiologicCell therapy (including stem cell therapy)
Industry: Investors

Drug pipeline

3 assets

Pneumoperitoneum Assist Device

Development

Indications: Laparoscopic surgery

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on TauTona Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TauTona Group.

Explore the full profile